Drug Formulary Review articles from June 2005

Drug Formulary Review archives from June 2005

How safe is your pharmacy? Be on the lookout.(Interview)
June 1, 2005... .table { border-collapse: collapse; border-color: #000000; } How safe is your pharmacy? Be on the lookout Impostors raise red flags about overall hospital security The Joint Commission on Accreditation of Healthcare Organizations...

Get a jump-start on improving your informatics.
June 1, 2005... Get a jump-start on improving your informatics The Internet may provide a partial solution The transition into the digital information world has not been smooth for most hospital pharmacists - or health care in general. "If you...

Take a closer look when assessing renal function.
June 1, 2005... Take a closer look when assessing renal function Prediction should be adjusted based on muscle mass  Two men are admitted to the hospital. One is a bodybuilder and looks like Arnold Schwarzenegger. The other is obese and describes...

Research News: Investigators release data on unexpected ADRs.(adverse drug events and reports)
June 1, 2005... Investigators release data on unexpected ADRs Ten percent of patients died from adverse reactions In 1998, a multidisciplinary team of investigators initiated RADAR (Research on Adverse Drug events And Reports), a clinically based...

News Briefs.
June 1, 2005... Gefitinib for advanced lung cancer trial closes early Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC)...

Drug Criteria & Outcomes: Poractant alfa (Curosurf) Formulary Evaluation.
June 1, 2005... Drug Criteria & Outcomes Poractant alfa (Curosurf) Formulary Evaluation By Penny Jones, PharmD candidate Harrison School of Pharmacy Auburn (AL) University Background Respiratory Distress Syndrome (RDS), also known as...

In the Pipeline.
June 1, 2005... * Millennium Pharmaceuticals has initiated EVEREST (Evaluation of Velcade [bortezomib] Employed as Retreatment for Efficacy, Safety, and Tolerability). This is a multicenter Phase IV clinical trial of bortezomib in multiple myeloma patients who...

New FDA Approvals.
June 1, 2005... These drugs were recently approved by the FDA: * Entecavir (Baraclude) by Bristol-Myers Squibb Co. The FDA has announced the approval of entecavir (Baraclude) tablets and oral solution for the treatment of chronic hepatitis B in adults....

CE Questions.
June 1, 2005... CE questions Pharmacists participate in this continuing education program by reading the article, using the provided references for further research, and studying the CE questions. Participants should select what they believe to be the...